Method of prognosis of metastasis by detection of FRA12E fragile site within the SMRT gene/locus at chromosome 12q24

Details for Australian Patent Application No. 2005212401 (hide)

Owner Health Research, Inc.

Inventors Coignet, Lionel J.

Agent Watermark

Pub. Number AU-A-2005212401

PCT Pub. Number WO2005/078136

Priority 60/542,538 06.02.04 US

Filing date 7 February 2005

Wipo publication date 25 August 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/078136 Priority application(s): WO2005/078136

2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212405-Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors

2005212399-Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof